News and Events > Newsletters > Monthly Newsletter: July 2004
University of Colorado Technology Transfer Office
Monthly Newsletter
Volume 1 ~ Issue 1 ~ July 2004
Welcome to the first issue of the University of Colorado Technology Transfer Office (TTO) monthly newsletter. The TTO is the CU organization that licenses intellectual property invented at CU's campuses. The monthly newsletter will bring you information about recent CU inventions, announcements about entrepreneurial activity, licensing deals and patents, as well as news about technology transfer around the country. Please feel free to forward this newsletter to any of your colleagues who may be interested in technology
commercialization at CU. If you do not care to receive this newsletter, simply unsubscribe at the bottom of this issue.
-Thank You
David Allen, Assoc. VP for Technology Transfer, CU System
Top Stories
Pearson Education Acquires Company Founded By CU Researchers
Pearson Education, the world's largest education company, announced June 29 its acquisition of Knowledge Analysis Technologies, a privately held Boulder-based
company that provides products and services based on proprietary and patented machine-learning technology for text understanding. Much of the core intellectual property, including the essay grading technology, was developed at theUniversity of Colorado at Boulder. (more)
TTO Announces Proof of Concept Program
The University of Colorado's Technology Transfer Office (TTO) announces a new funding program designed to move ideas from the lab to the marketplace. The Proof-of-Concept program (POC) will make "seed" investments ranging from $50,000 - $100,000 in promising technologies that could become the basis for a start-up company. A CU faculty member, or an entrepreneur working with a CU faculty member, must submit proposals by August 31, 2004. (more)
Today at the TTO
TTO Summer Program in Full Swing
The University of Colorado's Technology Transfer Office has launched its second summer of the "Colorado Technology Commercialization
Partnership (CTCP)". The program is an initiative supported by the TTO, the Deming Center for Entrepreneurship, and the Colorado Institute of Technology. (more)
University of Colorado Health Sciences Center Faculty Patent Upheld by Federal Circuit Court
The U.S. Federal Circuit Court of Appeals recently issued a ruling favorable to two University of Colorado inventors, upholding an earlier jury verdict and a Colorado District Court decision. The appeals court found Laboratory Corporation of America (LabCorp) liable for willful infringement of patent rights to a widely-used medical diagnostic test. (more)
Fiscal Year 2004 Annual Report
The TTO Annual Report is due out early this fall. Highlights include a disclosure increase of 19%, a 24% increase in executed agreements, and a 64% increase in royalty revenue. (more)
TTO in the News
ALD Nanosolutions
Particle-ALD, a nanomaterials building block invented at the University of Colorado (CU) and developed by ALD NanoSolutions, Inc., has been selected R&D Magazine as one of the 100 most technologically significant products introduced into the world marketplace over the past year. The R&D 100 Awards, which the Chicago Tribune dubbed "The Oscars of Invention," will be presented Oct. 14 at a banquet in Chicago. Nominations for the award include entries from prestigious companies, research organizations and universities around the world. (more)
Eyetech
Eyetech, a biopharmaceutical company collaborating with Pfizer for drug development derived from a CU discovery, recently announced the filing of a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The companies are seeking approval for Macugen(TM) (pegaptanib sodium injection) as a treatment for wet age-related macular degeneration. Macugen has received fast track status from the FDA, a designation for products that address unmet medical needs. The FDA recently announced that its Dermatologic and Ophthalmic Drugs Advisory Committee will review Macugen on August 27, 2004.
As the first biotechnology IPO of 2004, Eyetech netted $142.9 million upon completion of its public offering in February. As of July 14th, Eyetech's current share price is $44.50.
IP Servicing Agreements
The University of Colorado System Technology Transfer Office (TTO) and The Children's Hospital Association have announced that TTO will provide intellectual property (IP) and technology licensing services to The Children's Hospital. The agreement grows out of a long-standing and productive affiliation between the two institutions, which includes plans for creating adjacent new facilities on the former Fitzsimons Army base in Aurora. (more)
Spotlight On:
| CU's Technology of the Month |
CU's Startup Company of the Month |
| CU1012B - Lyotropic Liquid Crystal Nanofiltration Membranes |
Kapteyn-Murnane Labs |
| Dr. Douglas Gin and his group have fabricated a new type of composite polymer nanofiltration membrane that contains ordered, densely packed, size-tunable pores of uniform size, permitting size-selective separation of water-soluble substrate molecules in the 0.5-2.0 nm range. |
A licensee of CU technology, KM Labs leads the field in ultra-fast laser technology research and product development. The company, founded in 1999 by Drs. Henry Kapteyn and Margaret Murnane, is a growing business with an increasingly diverse product offering. KM Labs recently announced the launch of the Dragon(tm), the highest average power, shortest pulse, ultra fast ti:sapphire laser system on the market. |
Search our database for licenseable CU Technologies
Technology Transfer Bulletin of the Month
Upcoming Events
TTO Legal Seminar: "The Patenting of Bioinformatics Technologies," August 27, 2004
The CU Technology Transfer Office and the law offices of Quine Intellectual Property Law Group present the TTO Legal Seminar: "The Patenting of Bioinformatics Technologies" with Chris Sappenfield of Quine Intellectual Property Law Group.
Innovation in the News
University of Illinois group secures new fund $20 million for venture capital
The Illinois Emerging Technologies Fund recently closed on $20 million to invest in start-up companies commercializing technology developed at the U of Illinois and other Illinois research centers.
Bioterror Art Case Ongoing
The Federal Bureau of Investigation (FBI) has questioned two University of Pittsburgh genetics researchers in connection with a grand jury probe into possible violations of a US anti-bioterrorism law by a Buffalo art professor. Meanwhile, two more subpoenas have been issued in the case, one to a former student of the professor and the other to the publisher of five books the professor wrote with colleagues.
Patent Law Update
An important university biotech case that could significantly impact patent law may be headed to the Supreme Court - if the University of Rochester has its way. At issue is whether a patent can be held invalid if it fails to provide a "written description" of the invention.
|
